5.35
                                            Schlusskurs vom Vortag:
              $5.84
            Offen:
              $5.85
            24-Stunden-Volumen:
                6.95M
            Relative Volume:
              1.15
            Marktkapitalisierung:
                $1.15B
            Einnahmen:
              $2.59M
            Nettoeinkommen (Verlust:
              $-137.89M
            KGV:
              -6.6049
            EPS:
                -0.81
            Netto-Cashflow:
                $-69.76M
            1W Leistung:
              -13.99%
            1M Leistung:
              +2.29%
            6M Leistung:
                +256.67%
            1J Leistung:
              +395.37%
            Atai Life Sciences N V Stock (ATAI) Company Profile
Firmenname
                  
                      Atai Life Sciences N V
                    
                Sektor
                  Branche
                  Telefon
                  
                      49 89 2153 9035
                    
                Adresse
                  
                      PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
                    
                Vergleichen Sie ATAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ATAI
                            
                             
                        Atai Life Sciences N V 
                           | 
                    5.35 | 1.56B | 2.59M | -137.89M | -69.76M | -0.81 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-10-13 | Eingeleitet | Needham | Buy | 
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform | 
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy | 
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy | 
| 2022-11-01 | Eingeleitet | Loop Capital | Buy | 
| 2021-11-30 | Eingeleitet | Maxim Group | Buy | 
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy | 
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy | 
| 2021-09-01 | Eingeleitet | Jefferies | Buy | 
| 2021-07-13 | Eingeleitet | Berenberg | Buy | 
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy | 
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy | 
| 2021-07-13 | Eingeleitet | Citigroup | Buy | 
| 2021-07-13 | Eingeleitet | Cowen | Outperform | 
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform | 
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform | 
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy | 
                    Alle ansehen
                    
                  
                Atai Life Sciences N V Aktie (ATAI) Neueste Nachrichten
Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsPortfolio Update Summary & Long-Term Safe Investment Plans - newser.com
Is Atai Life Sciences N.V. (9VC) stock trading at attractive multiplesMarket Trend Review & Reliable Entry Point Alerts - newser.com
Is Atai Life Sciences N.V. stock poised for growthJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - newser.com
Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakout - newser.com
Is Atai Life Sciences NV a good long term investmentSmall Cap Stock Opportunities & High Yield Trading Signals - earlytimes.in
Is Atai Life Sciences N.V. stock a defensive play in 2025Analyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Published on: 2025-11-03 03:02:35 - newser.com
Building trade automation scripts for Atai Life Sciences N.V.2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Chart based analysis of Atai Life Sciences N.V. trendsQuarterly Market Review & Technical Confirmation Alerts - newser.com
Will Atai Life Sciences N.V. (9VC) stock test record highs in 2025Market Activity Summary & Free High Return Stock Watch Alerts - newser.com
Will Atai Life Sciences N.V. (9VC) stock outperform energy sector in 2025Portfolio Growth Summary & Long-Term Growth Stock Strategies - newser.com
Will Atai Life Sciences N.V. (9VC) stock justify high valuation - newser.com
Combining machine learning predictions for Atai Life Sciences N.V.Weekly Stock Analysis & Short-Term High Return Ideas - newser.com
Why analysts recommend Atai Life Sciences N.V. (9VC) stockEarnings Risk Summary & Safe Entry Zone Tips - newser.com
Will Atai Life Sciences N.V. stock sustain high P E ratiosJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
Will Atai Life Sciences N.V. stock reach all time highs in 2025Market Trend Report & Safe Capital Growth Tips - newser.com
Ranking Atai Life Sciences N.V. among high performing stocks via tools2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Published on: 2025-11-01 04:43:33 - newser.com
Why Atai Life Sciences N.V. stock appeals to dividend seekersJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com
Understanding Atai Life Sciences N.V.’s price movement2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Can Atai Life Sciences N.V. stock resist sector downturns2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
Atai Life Sciences N.V. stock trend forecastTrade Volume Summary & Fast Moving Market Watchlists - newser.com
Published on: 2025-10-30 23:24:14 - newser.com
Atai Life Sciences N.V. (ATAI) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Can machine learning forecast Atai Life Sciences N.V. recovery2025 Market Overview & Risk Managed Trade Strategies - newser.com
Finanzdaten der Atai Life Sciences N V-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):